Call For Participants

Elevating the Future of Multi-Specialty Medication Access and Patient Support.

May 26-29, 2026 — Nashville, TN

Under the Specialty Summit USA umbrella, we invite you to join us as a participant in an expansive conference series spanning 11 therapeutic areas.

Each summit is intentionally designed to deliver specialty-specific insight while fostering cross-functional collaboration, candid dialogue, and shared learning across the access ecosystem.

The Specialty Summit USA brings together senior executives and front-line experts across biopharma, specialty pharmacy, technology, advocacy, and care delivery to:

  • Engage in structured, candid dialogue grounded in real-world execution

  • Surface field-validated insights that inform access strategy, program design, and product planning

  • Align cross-functional stakeholders around real-time operational and access challenges

  • Identify disconnects between policy intent and on-the-ground execution before they become systemic barriers

  • Co-create practical solutions that accelerate patient access and support across complex specialty therapies

  • Participate in experience-driven, professionally moderated discussions designed to inform decision-making and guide action

Submission Timeline

Round 1 Submissions Close January 31st, 2026 at 11:59 PM ET
Submissions will be reviewed on a rolling basis to ensure balanced, high-impact discussions across stakeholder groups and therapeutic areas.

A second round may open if additional perspectives are needed to complete the program.

Participation is curated to maintain the integrity and quality of the conversation.

Agenda Overview

At the Specialty Summit USA, you will engage in practical, real-world conversations focused on navigating medication access across complex, multi-specialty care pathways. Every session is built for execution — connecting policy, affordability, distribution, and frontline experience to drive meaningful progress in patient access.

Key Sessions include:

  • Registration & Networking Breakfast

  • Opening Remarks: Aligning on the Realities of Access Today

  • Opening Keynote: The State of Access in 2026 — Policy, Cost, and Patient Impact

  • Coverage Is Not Access: Evaluating Payer Policy Performance in Practice

  • Utilization Management in Execution: Where Policy Design Meets Operational Reality

  • The Affordability Gap: When Coverage Exists but Treatment Still Stalls

  • Lunch & Peer Networking

  • Specialty Distribution Strategy and System-Wide Impact

  • HUB Models at an Inflection Point: Performance, Alignment, and What Comes Next

  • Frontline Impact: How Access Decisions Affect Patients and Care Teams

  • Closing Executive Panel: The Path Forward — Aligning Policy, Operations, and Patient Impact

If you are shaping the strategy behind tomorrow’s therapies — this is where your next breakthrough conversation begins.

The 2026 Specialty Summit USA portfolio includes:

Wednesday, May 27, 2026

Thursday, May 28, 2026

Friday, May 29, 2026

Who Should Attend

This summit is built for innovators shaping the future of advanced therapies — those bringing cell and gene treatments from development to delivery.

You’ll find immense value if you’re focused on:

  • Navigating access and reimbursement realities for high-cost, one-time therapies

  • Designing patient support strategies that align with payer expectations and policy shifts

  • Building launch frameworks that integrate affordability, sustainability, and stakeholder trust

  • Collaborating across providers, payers, and partners to strengthen real-world implementation

  • Translating innovation into impact — ensuring every approved therapy reaches the patients it was created for

If you’re ready to move beyond the science to solve the access equation, this summit is where the right conversations — and the right connections — happen.

    • Vice Presidents and Directors of Market Access

    • Managed Markets and Reimbursement Strategy Executives

    • Commercial Operations and Field Deployment Leaders

    • Franchise Heads and Brand Directors by Therapeutic Area

    • Business Development and Strategic Partnerships LeadersDescription text goes here

    • Patient Access Services Executives

    • HUB Program Directors and Managers

    • Co-Pay and Affordability Strategy Leaders

    • Specialty Pharmacy Integration Managers

    • Medical Affairs Directors and Field MSL Leads

    • Clinical Development and Investigator Relations Teams

    • Scientific Communications and Evidence Generation Leaders

    • HEOR (Health Economics & Outcomes Research) Executives

    • RWE (Real-World Evidence) and Outcomes Analytics Directors

    • Payer Evidence & Value Communication Leads

    • Government Affairs and Public Policy Executives

    • Advocacy Relations Directors

    • Public-Private Partnership Development LeadersItem description

    • Trade and Distribution Executives

    • Specialty Pharmacy Relations Managers

    • Digital Therapeutics and Telehealth Commercial Teams

  • Specialty pharmacies, HUBs, technology platforms, and access partners that work alongside pharmaceutical manufacturers to support every step of the patient journey—streamlining medication access, enhancing affordability support, and removing barriers to ensure timely, coordinated care.

  • Pharmacies that manage the distribution and support of high-cost, complex therapies—ensuring patients receive timely access, education, and coordinated care.

  • Mission-driven organizations that provide critical support services, financial assistance, education, and advocacy to reduce barriers and improve access for underserved patient populations.

  • If your organization is navigating medication access, reimbursement, or patient affordability challenges — this is the meeting for your team.

    Recommended roles include:

    • Executive Leadership: Chief Medical Officer, Chief Pharmacy Officer, Chief Operating Officer, Chief Nursing Officer, VP of Specialty Services, or VP of Population Health

    • Pharmacy & Clinical Management: Pharmacy Director, Specialty Pharmacy Manager, Infusion Center Manager, Ambulatory Care Director, or Clinical Pharmacist Leader

    • Access & Financial Navigation Teams: Director of Patient Access, Financial Counselor Manager, Reimbursement Manager, Medication Assistance or Financial Navigation Program Lead

    • Practice Administration: Practice Manager, Billing and Coding Lead, Compliance Officer, Revenue Cycle Director, or Payer Relations Manager

    • Independent Practices & Specialty Clinics: Physicians, Nurse Practitioners, Office Managers, or Access Coordinators working directly with patients and payers

Why the Specialty Summit USA Matters

The future of medicine is being shaped right now and it can’t be written by science alone. Breakthrough therapies only change lives if patients, providers, payers, and policymakers work together to remove barriers and build new models of care. The eleven summits is a catalyst for that collaboration, bringing every voice to the table so progress in the lab becomes progress in the real world.

  • "The level of candor in the room was refreshing. Front-line challenges were named, unpacked, and treated with the seriousness they deserve."

    —Head of Market Access

  • "Every detail was thoughtfully executed. We were thrilled with the insights, and outcome."

    —Former Attendee

  • "Every disease state brings distinct complexities and access barriers. This conversation finally created the space to drill into them deeply, thoughtfully, and with real-world insight."

    —Market Access & Patient Services

  • "A professional team that delivers on their promises."

    —Former Sponsor

Learn About Our Other Events